October 13, 2009
Optimata Releases a New Version of its Virtual Patient
|
|
June 30, 2009
Optimata to Collaborate with Teva Pharmaceutical Industries Ltd. on Clinical Development of Solid Tumor Cancer Drugs
|
|
November 24, 2008
Optimata to Present Virtual Patient That Predicts Response to Cancer Drugs at UK Conference
|
|
October 27, 2008
“Cancer Research” Journal Publishes Successful Angiogenesis Study Using Optimata’s Technology. Prof. Agur to Speak at M. D. Anderson Cancer Center Symposium on Oct. 30
|
|
October 15, 2008
Optimata to Chair a Session on Repurposing Failed Drugs at Les Annual Meeting
|
|
August 26, 2008
Optimata Granted Patent for Modeling Angiogenesis and Providing Optimal Treatment
|
|
February 13, 2008
Optimata Obtains $1.5 M for BioSimulation-Based Renewal of Discontinued Cancer Drugs
|
|
September 11, 2007
Optimata Granted Patent For Granulopoiesis-Modelling System, Can Optimize Cancer Drug
Development With Less Toxicity
|
|
April 26, 2007
Optimata Virtual Patient®Approved as a Registered Trademark
New Targeted Therapeutics Module Launched
|
|
January 8, 2007
Eli Lilly Extends Cooperation with Optimata, Developer of Virtual Patient Technology
|
|
December 19, 2006
Optimata Granted Patent for Modeling Thrombopoiesis
|
|
October 17, 2006
Optimata Completes Successful Breast Cancer Clinical Study: 70% Prediction Accuracy Offers New Hope for Cancer Patients
|
|
August 14, 2006
Optimata, Developer of Virtual Patient Biosimulation Technologies, Appoints Dr. David Sidransky to Scientific Board
|
|
March 27, 2006
Optimata's Virtual Patient Technology to support development of Eli Lilly Drug Candidate
|
|
January 26, 2006
Optimata Granted Patent for Use of Virtual Patient Technology in Cancer
|
|
July 20, 2005
New Optimata Technology Predicts Drug Response to Breast Cancer within 24 Hours
|
|
April 12, 2005
Optimata, Developer of Predictive Biosimulation for Drug Development, Appoints Guy Malchi President
|
|
February 3, 2005
Optimata's Virtual Clones to Predict Therapy Outcome for Breast Cancer Adriamycin, Docetaxel, Paclitaxel, Vinorelbine and Tamoxifen in Validation Study
|
|
December 8, 2004
Breast Cancer Patients Get Individualized Therapy in Nottingham Trial First-Ever Use of Computer Models in individual Cancer Therapy
|
|
November 10, 2003
Study Shows How Optimata Technology Can Save Stalled TPO Drug New BioSimulation Technology Transforms Drug Development
|
|
